文献速递肿瘤 PET/CT

68Ga-PSMA-11 PET/CT在前列腺腺癌孤立性壁层腹膜转移病例中的应用

68Ga-PSMA-11 PET/CT in a Case of Isolated Parietal Peritoneal Metastasis From Prostate Adenocarcinoma.
PubMed 文献 · Clin Nucl Med · 2023-08-30

本文报告一例前列腺腺癌根治性前列腺切除术后35个月出现孤立性壁层腹膜转移的病例,68Ga-PSMA-11 PET/CT显示腹膜转移灶多灶性强烈PSMA摄取但结构异常轻微。患者接受雄激素剥夺治疗,25个月后腹膜转移进展并手术切除,组织学及免疫组化证实为转移性前列腺腺癌伴治疗相关神经内分泌分化。本病例表明68Ga-PSMA-11 PET/CT有助于识别前列腺腺癌的非典型转移。

要点

  • 前列腺癌孤立性腹膜转移极罕见,本例发生于根治性前列腺切除术后35个月。
  • 68Ga-PSMA-11 PET/CT显示腹膜转移灶多灶性强烈PSMA摄取,但结构异常轻微。
  • 雄激素剥夺治疗25个月后腹膜转移进展,手术切除后证实伴治疗相关神经内分泌分化。

核心结论

  • 本病例表明68Ga-PSMA-11 PET/CT有助于识别前列腺腺癌的非典型转移。

研究设计与样本

  • 个案报道,描述一例前列腺腺癌孤立性壁层腹膜转移患者的68Ga-PSMA-11 PET/CT表现及后续诊疗经过。

主要发现

  • 前列腺腺癌根治性前列腺切除术后35个月出现孤立性壁层腹膜转移。
  • 腹膜转移灶在68Ga-PSMA-11 PET/CT上表现为多灶性强烈PSMA摄取,但结构异常轻微。
  • 患者接受雄激素剥夺治疗,25个月后腹膜转移进展并手术切除。
  • 组织学及免疫组化评估显示转移性前列腺腺癌伴治疗相关神经内分泌分化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Isolated peritoneal metastasis of prostate cancer is extremely rare. We present 68Ga-PSMA-11 PET/CT findings in a case of isolated parietal peritoneal metastasis from prostate adenocarcinoma 35 months after radical prostatectomy. The peritoneal metastases showed multifocal intense PSMA uptake, but subtle structural abnormalities on 68Ga-PSMA-11 PET/CT. The patient was subsequently treated with androgen deprivation therapy. The peritoneal metastases progressed 25 months after the initiation of androgen deprivation therapy and were removed surgically. Histologic and immunohistochemical evaluation revealed metastatic prostate adenocarcinoma with treatment-related neuroendocrine differentiation. This case demonstrates the usefulness of 68Ga-PSMA-11 PET/CT in identifying atypical metastasis from prostate adenocarcinoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Zhao Q, Dong A, Zuo C, et al. 68Ga-PSMA-11 PET/CT in a Case of Isolated Parietal Peritoneal Metastasis From Prostate Adenocarcinoma. Clin Nucl Med. 2023. PMID: 37682611. doi:10.1097/RLU.0000000000004805

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。